|
ZNF800 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.356800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.037200E-01 |
| Normal-vs-Stage2 |
7.435000E-01 |
| Normal-vs-Stage3 |
1.441950E-01 |
| Normal-vs-Stage4 |
1.032060E-02 |
| Stage1-vs-Stage2 |
8.312800E-01 |
| Stage1-vs-Stage3 |
7.237600E-02 |
| Stage1-vs-Stage4 |
2.222000E-03 |
| Stage2-vs-Stage3 |
2.550800E-01 |
| Stage2-vs-Stage4 |
8.080200E-02 |
| Stage3-vs-Stage4 |
3.078600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.323400E-01 |
| Normal-vs-AfricanAmerican |
8.559200E-03 |
| Normal-vs-Asian |
8.014600E-01 |
| Caucasian-vs-AfricanAmerican |
1.317720E-02 |
| Caucasian-vs-Asian |
7.792000E-01 |
| AfricanAmerican-vs-Asian |
1.866990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.285800E-01 |
| Normal-vs-Female |
9.063200E-01 |
| Male-vs-Female |
1.767240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.331200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.016800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.852600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.192200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.508000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.190000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.197600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.976600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.368600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.913000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.231000E-01 |
| Normal-vs-Grade 2 |
3.403000E-01 |
| Normal-vs-Grade 3 |
7.494300E-02 |
| Normal-vs-Grade 4 |
1.618920E-03 |
| Grade 1-vs-Grade 2 |
6.744000E-01 |
| Grade 1-vs-Grade 3 |
2.841200E-01 |
| Grade 1-vs-Grade 4 |
1.160840E-01 |
| Grade 2-vs-Grade 3 |
5.038100E-03 |
| Grade 2-vs-Grade 4 |
8.39650000000747E-05 |
| Grade 3-vs-Grade 4 |
4.391700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.524000E-02 |
| Normal-vs-ccB subtype |
1.246230E-01 |
| ccA subtype-vs-ccB subtype |
3.170400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.315400E-01 |
| Normal-vs-N1 |
3.907200E-01 |
| N0-vs-N1 |
4.231400E-01 |
|
|
